| 1 |
18607107 | Development of Crohn's disease in a patient with multiple sclerosis treated with copaxone. | 2008 |
1 |
| 2 |
17531858 | Glatiramer acetate: mechanisms of action in multiple sclerosis. | 2007 |
1 |
| 3 |
19300558 | Glatiramer acetate in the treatment of multiple sclerosis. | 2007 Apr |
1 |
| 4 |
16608409 | Immunomodulatory vaccines against autoimmune diseases. | 2006 Spring |
2 |
| 5 |
15308777 | Therapeutic vaccines in autoimmunity. | 2004 Oct 5 |
1 |
| 6 |
12725872 | Glatiramer acetate (Copaxone) therapy for multiple sclerosis. | 2003 May |
1 |
| 7 |
9846830 | Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. | 1998 Nov 2 |
2 |
| 8 |
9237101 | Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells. | 1997 Jul |
2 |
| 9 |
8965119 | New insights into the mechanism of action of copolymer 1 in experimental allergic encephalomyelitis and multiple sclerosis. | 1996 Apr |
1 |
| 10 |
1370347 | Synthetic copolymer 1 inhibits human T-cell lines specific for myelin basic protein. | 1992 Jan 1 |
1 |
| 11 |
2462252 | Specific inhibition of the T-cell response to myelin basic protein by the synthetic copolymer Cop 1. | 1988 Dec |
1 |